Skip to main content
American Journal of Epidemiology logoLink to American Journal of Epidemiology
. 2020 Oct 15;190(3):431–438. doi: 10.1093/aje/kwaa223

Prepubertal Internalizing Symptoms and Timing of Puberty Onset in Girls

Julia A Knight , Rebecca D Kehm, Lisa Schwartz, Caren J Frost, Wendy K Chung, Sarah Colonna, Theresa H M Keegan, Mandy Goldberg, Lauren C Houghton, Danielle Hanna, Gord Glendon, Mary B Daly, Saundra S Buys, Irene L Andrulis, Esther M John, Angela R Bradbury, Mary Beth Terry
PMCID: PMC8086416  PMID: 33057572

Abstract

Stressful environments have been associated with earlier menarche. We hypothesized that anxiety, and possibly other internalizing symptoms, are also associated with earlier puberty in girls. The Lessons in Epidemiology and Genetics of Adult Cancer From Youth (LEGACY) Girls Study (2011–2016) included 1,040 girls aged 6–13 years at recruitment whose growth and development were assessed every 6 months. Prepubertal maternal reports of daughter’s internalizing symptoms were available for breast onset (n = 447), pubic hair onset (n = 456), and menarche (n = 681). Using Cox proportional hazard regression, we estimated prospective hazard ratios and 95% confidence intervals for the relationship between 1 standard deviation of the percentiles of prepubertal anxiety, depression, and somatization symptoms and the timing of each pubertal outcome. Multivariable models included age, race/ethnicity, study center, maternal education, body mass index percentile, and family history of breast cancer. Additional models included maternal self-reported anxiety. A 1–standard deviation increase in maternally reported anxiety in girls at baseline was associated with earlier subsequent onset of breast (hazard ratio (HR) = 1.22, 95% confidence interval (CI): 1.09, 1.36) and pubic hair (HR = 1.15, 95% CI: 1.01, 1.30) development, but not menarche (HR = 0.94, 95% CI: 0.83, 1.07). The association of anxiety with earlier breast development persisted after adjustment for maternal anxiety. Increased anxiety in young girls may indicate risk for earlier pubertal onset.

Keywords: breast development, cohort study, girls, internalizing symptoms, puberty

Abbreviations

BCFH

breast cancer family history

BMI

body mass index

CI

confidence interval

HR

hazard ratio

LEGACY

Lessons in Epidemiology and Genetics of Adult Cancer From Youth

TS

Tanner stage

Age at onset of breast development, a common indicator of puberty onset, has become younger in recent decades, although the average age at menarche has remained stable (1, 2). Earlier puberty in girls is associated with a variety of adverse physical and mental health outcomes (1, 3, 4). Thus, it is important to understand the factors that contribute to pubertal onset and progression, particularly those potentially amenable to intervention. Several factors, such as obesity and genetics, play a role, but the factors contributing to variation in pubertal developmental timing are not fully understood (1, 2, 4).

Stress has been associated with the timing of pubertal development in girls, although this area of research is complex, with varied definitions of stress (1, 5). Most evidence to date is based on the association of systems-level factors such as socioeconomic status, familial characteristics, and number of adverse childhood events with the timing of the development of pubertal characteristics, usually menarche (1, 5). Although stressful environments involving inadequate nutrition are associated with pubertal delays, adverse psychosocial conditions may accelerate pubertal development (1, 5).

Few studies have examined individual indicators of stress. Earlier menarche has been associated prospectively with higher scores of socioemotional difficulties at age 7 years (6) and retrospectively with recalled anxiety or a combined measure of anxiety and depression in late childhood (7). To our knowledge, no study to date has prospectively assessed the relationship of anxiety and other internalizing symptoms (related to anxiety and depression) in prepubertal girls with the timing of the appearance of characteristics indicating pubertal onset (i.e., breast and pubic hair development). Understanding the relationship between psychosocial factors and pubertal development is relevant because it may enhance the ability to identify girls at risk of earlier puberty and indicate modifiable targets of intervention.

Therefore, we assessed the relationship between symptoms of anxiety, depression, and somatization (i.e., the manifestation of depression and/or anxiety as physical symptoms), as well as a composite score of internalization, in prepubertal girls participating in the Lessons in Epidemiology and Genetics of Adult Cancer From Youth (LEGACY) Girls Study (8) and the timing of subsequent development of pubertal characteristics (i.e., pubic hair and breast development and menarche). We hypothesized that higher scores for anxiety and potentially other symptoms of internalizing, as reported by mothers before the appearance of pubertal signs, would be associated with earlier pubertal development. We also investigated whether increased self-reported maternal stress, anxiety, and depression, as well as family functioning and communication, were associated with pubertal timing in daughters, because these factors may independently influence pubertal timing and/or influence maternal reporting of pubertal signs.

METHODS

Study sample

The LEGACY Girls Study is a prospective cohort of 1,040 girls enrolled at 5 study sites in the United States (New York City, New York; Philadelphia, Pennsylvania; Salt Lake City, Utah; San Francisco Bay area, California) and Canada (Toronto, Ontario) from 2011 through 2013 (8, 9). These are the 5 North American sites of the Breast Cancer Family Registry cohort of breast cancer families (10, 11). Girls with a breast cancer family history (BCFH) were recruited through Breast Cancer Family Registry participants, local cancer registries, and cancer genetics and oncology clinics. Girls, usually without a BCFH, were also recruited through local pediatric practices, friend referrals, social media, and community outreach. Girls were primarily between the ages of 6 and 13 years at recruitment and 51% had a BCFH, defined as breast cancer in a first- or second-degree relative. The mother was the participating guardian for 97% of the girls. For this study, which relied on maternal reports, we excluded the 3% of girls without a participating mother.

Questionnaires and measurements were administered at baseline and every 6 months thereafter. The current analysis includes prospective follow-up data collected through August 2016. Mothers provided written informed consent for themselves and their daughters. Daughters also provided written informed assent according to local institutional standards. The study was approved by the institutional review boards of the collaborating institutions.

Of the 1,040 girls in the cohort, 861 (83%) had internalizing symptom data reported by their mothers as described later in this section (n = 697 mothers, some with multiple daughters participating, also reported information on their own symptoms and family functioning). Information was missing on breast development for 3 girls and on pubic hair development for 12 girls. No girls were missing menarche information. Analyses of each outcome excluded girls who had already experienced the outcome at baseline (thus, there was no left censoring), leaving 447 girls in the analyses of breast development onset (n = 320 subsequently started breast development; n = 120 were censored), 456 girls in the analyses of pubic hair onset (n = 271 subsequently started pubic hair development; n = 185 were censored), and 681 in the analyses of menarche (n = 294 subsequently started menstruating; n = 387 were censored). Although girls reported on their own development and some psychosocial characteristics from the age of 10 years, by this age, 40% of girls had begun breast development. Therefore, to avoid bias associated with restricting analysis to girls with later pubertal onset, we used maternal reports, because these were available across all ages.

Growth and development

We assessed pubertal development by questionnaire every 6 months. Mothers assessed their daughters’ stages of breast and pubic hair development using the Sexual Maturation Scale (12) that shows drawings of the 5 Tanner stages (TS) (13). Breast TS2 and pubic hair TS2 indicate the onset of breast and pubic hair development, respectively (13). We previously found maternal reports of breast onset using this approach to be highly reliable (κ = 0.73) and valid (sensitivity = 77%; specificity = 94%) in a subset of girls in the LEGACY Study who also had clinical breast TS (14). Where applicable, mothers reported their daughter’s age at menarche in half-year intervals. We were not able to examine pubertal tempo (i.e., the timing of progression through pubertal stages) because we did not have sufficient follow-up for the different outcomes within the same individual. Height and weight were measured twice every 6 months by trained research staff using a stadiometer and a digital scale. We used the averages to calculate body mass index (BMI), defined as weight (kg) divided by square of height (m2), and calculated the percentiles for age using the 2000 US Centers for Disease Control and Prevention growth charts (15). Models included the baseline BMI percentile.

Psychosocial measures

As previously described (16), mothers completed behavioral surveys before other baseline study assessments. These surveys included maternal report of girls’ functioning using the Behavioral Assessment System for Children-2, a tool used in clinical assessment of child behavior and emotion. Mothers completed the Internalizing Composite Scale, which includes subscales for anxiety, depression, and somatization, with established criteria for clinical at-risk status (t ≥ 60) (17). We used the individual scores for each subscale as well as the internalizing composite scale score. (17). Percentiles were used as in our previous work (16). Maternal anxiety and depression symptoms were assessed using the Hospital Anxiety and Depression Scale (18, 19). Mothers also reported on their stress using the Perceived Stress Scale (20) and on family functioning and communication using the general function and communication subscales of the McMaster Family Assessment Device (21, 22).

Statistical analysis

We examined associations of psychosocial measures with timing of pubertal outcomes using multivariable Cox proportional hazards regression (23). Follow-up time was calculated from the date of baseline behavioral assessment in prepubertal girls to the midpoint between the date when the mother last reported TS1/premenarche and the date when the mother first reported TS2/menarche. Girls who did not transition to TS2 or menarche during follow-up were censored at date of last follow-up. We adjusted models for aspects of our study design (study center; BCFH), variables known to be strongly associated with pubertal development (age at baseline, race/ethnicity, baseline BMI percentile), and an indicator of socioeconomic status (maternal education). We previously observed an association between BCFH and the timing of breast development onset in this cohort (9). We evaluated maternal age at menarche as a potential confounder, but we excluded it from final models because there was little impact on estimates. We used a robust variance estimator to account for familial clustering arising from the participation of siblings within the cohort.

The Cox proportional hazards assumption was assessed by testing for interactions between predictors and log-transformed time and by evaluating plots of smoothed and scaled Schoenfeld residuals over time. We found no evidence that the proportional hazards assumption was violated. We conducted sensitivity analyses using subgroup analyses in girls younger than 8 years at baseline (reducing enrichment for later pubertal onset), by race/ethnicity (non-Hispanic White girls and girls of all other race/ethnicities), and in the subset of girls with available clinical breast TS information. We also conducted sensitivity analyses examining associations using Weibull regression with interval censoring, rather than censoring at the midpoint, for girls who transitioned from TS1/premenarche to TS2/menarche between follow-up dates. This method requires more assumptions than does Cox proportional hazards regression, assuming the functional form of the baseline hazard in addition to assuming proportional hazard functions (24).

Finally, we conducted sensitivity analyses using age as the time scale. Both the Weibull regression and using age as the time scale produced estimates consistent with our primary analysis (data not shown). In the results, we present hazard ratios and 95% confidence intervals for each pubertal event associated with a 1–standard deviation change in the psychosocial factor. Statistical significance was defined as P < 0.05 for a 2-sided test. All analyses were conducted using Stata 15.1 (StataCorp LP, College Station, Texas).

RESULTS

Study population characteristics for each outcome are shown in Table 1. Overall, the girls demonstrated an average amount of internalizing symptoms as reported by their mothers (mean percentile scores close to 50). Mothers also did not have elevated scores of stress, anxiety, or depression overall. As expected, there were moderate correlations among all the scores (Web Table 1, available at https://academic.oup.com/aje). As described in Methods, internalizing is a composite of anxiety, depression, and somatization and, therefore, highly correlated with these subscales. The BMI percentile was not correlated with any psychosocial measures.

Table 1.

Baseline Characteristics in Each Analytic Subcohort of Girls Assessed Before the Onset of the Development of Pubertal Characteristics, the Lessons in Epidemiology and Genetics of Adult Cancer From Youth Girls Study (n = 1,040), 2011–2016

Characteristic Breast Development (n = 447) Pubic Hair Development (n = 456) Menarche (n = 681)
No. % Mean (SD) No. % Mean (SD) No. % Mean (SD)
Race/ethnicity
 Non-Hispanic White 316 70.7 326 71.5 469 68.9
 Other 131 29.3 130 28.5 212 31.1
Study center
 Philadelphia, PA 66 14.8 68 14.9 110 16.2
 New York, NY 78 17.5 76 16.7 112 16.5
 Salt Lake City, UT 89 19.9 88 19.3 118 17.3
 Toronto, ON, Canada 76 17.0 82 18.0 117 17.2
 San Francisco Bay area, CA 138 30.9 142 31.1 224 32.9
Maternal education
 Some college or less 93 20.8 99 21.7 151 22.2
 Bachelor’s degree 179 40.0 182 39.9 261 38.3
 Graduate degree 170 38.0 170 37.3 263 38.6
 Missing 5 1.1 5 1.1 6 0.9
Breast cancer family history
 None 235 52.6 228 50.0 349 51.3
 Second degree only 133 29.8 148 32.5 206 30.3
 First degree 79 17.7 80 17.5 126 18.5
Daughter’s age at behavioral assessment, years 8.6 (1.6) 8.6 (1.5) 9.4 (1.9)
Body mass index percentile 41.0 (28.2) 44.3 (29.5) 45.4 (29.7)
Maternal-reported internalizing symptoms in girlsa
 Anxiety 45.9 (28.9) 45.4 (29.1) 46.9 (29.3)
 Depression 53.3 (27.3) 52.6 (27.3) 52.5 (26.9)
 Somatization 46.4 (30.9) 46.4 (30.7) 46.6 (31.0)
 Internalizing 47.5 (29.4) 47.1 (29.7) 47.9 (29.4)
Maternal self-reported internalizing symptoms
 Stressb 4.8 (2.7) 4.9 (2.7) 4.8 (2.7)
 Anxietyc 7.0 (3.6) 7.0 (3.7) 6.9 (3.7)
 Depressionc 3.3 (2.7) 3.4 (2.8) 3.2 (2.8)
Family communicationd 17.9 (3.8) 18.1 (3.6) 18.0 (3.8)
Family functioningd 21.4 (5.3) 21.7 (5.2) 21.4 (5.3)

Abbreviations: CA, California; NY, New York; ON, Ontario; PA, Pennsylvania; SD, standard deviation; UT, Utah.

a Anxiety, depression, and somatization data from the internalizing subscales of the Behavior Assessment System for Children-2 (percentiles). Internalizing is a composite of the other scales.

b Perceived Stress Scale score.

c Hospital Anxiety and Depression Scales scores.

d General function and communication subscales of the McMaster Family Assessment Device.

Higher overall internalizing in the daughters, as reported by the mothers, was significantly associated with earlier onset of breast development, after adjustment for age at assessment, race/ethnicity, study center, maternal education, BMI percentile, and BCFH (Table 2). This relationship appeared to be largely driven by the association with the anxiety component of internalizing. There was a similar, but not statistically significant, association between earlier breast development and anxiety scores that were clinically high, which occurred in 56 girls (12.5%; hazard ratio (HR) = 1.23, 95% confidence interval (CI): 0.89, 1.71). Higher anxiety scores in the daughters were also associated with earlier onset of pubic hair, but not earlier menarche (Table 2). When the analysis was restricted to the subset of girls who were younger than 8 years at baseline, the associations with age at onset of breast development were slightly stronger (Table 3). Menarche cannot be examined in this age group because it is rare within our window of follow-up time.

Table 2.

The Association of Maternal-reported Internalizing Symptoms With the Timing of Subsequent Development of Pubertal Characteristics in All Girls Recruited Before Pubertal Onset, the Lessons in Epidemiology and Genetics of Adult Cancer From Youth Girls Study (n = 1,040), 2011–2016

Symptom in Girls Breast Development a Pubic Hair Development b Menarche c
HR d 95% CI P Value HR d 95% CI P Value HR d 95% CI P Value
Anxietye 1.22 1.09, 1.36 <0.001 1.15 1.01, 1.30 0.04 0.94 0.83, 1.07 0.35
Depressione 1.05 0.92, 1.19 0.49 1.09 0.96, 1.24 0.16 1.02 0.91, 1.15 0.73
Somatizatione 1.13 1.01, 1.27 0.04 1.06 0.93, 1.21 0.38 1.02 0.91, 1.15 0.70
Internalizinge 1.17 1.04, 1.32 0.01 1.12 0.98, 1.28 0.10 0.99 0.88, 1.12 0.90

Abbreviations: CI, confidence interval; HR, hazard ratio.

a  n = 447; no. of events = 320; cumulative days of follow-up = 293,741.

b  n = 456; no. of events = 271; cumulative days of follow-up = 343,183.

c  n = 681; no. of events = 294; cumulative days of follow-up = 601,318.

d HR is for a 1–standard deviation change in the psychosocial factor adjusted for age at assessment, race/ethnicity, study center, maternal education, body mass index percentile, breast cancer family history.

e Anxiety, depression, and somatization data from the parent-reported internalizing subscales of the Behavior Assessment System for Children-2 (percentiles). Internalizing is a composite of the other scales.

Table 3.

Association of Maternal-Reported Internalizing Symptoms With Timing of Subsequent Development of Pubertal Characteristicsa in Girls Aged < 8 Years and Prepubertal at Recruitment in the Lessons in Epidemiology and Genetics of Adult Cancer From Youth Girls Study (n = 1,040), 2011–2016

Symptom in Girls Breast Development b Pubic Hair Development c
HR d 95% CI P Value HR d 95% CI P Value
Anxietye 1.40 1.11, 1.76 0.01 1.23 0.94, 1.61 0.13
Depressione 1.28 1.03, 1.58 0.02 1.09 0.86, 1.40 0.47
Somatizatione 1.23 0.98, 1.53 0.07 1.08 0.82, 1.42 0.58
Internalizinge 1.37 1.10, 1.72 0.01 1.16 0.89, 1.51 0.27

Abbreviations: CI, confidence interval; HR, hazard ratio.

a Menarche could not be evaluated because few girls younger than 8 years reached menarche.

b  n = 181; no. of events = 93; cumulative days of follow-up = 160,913.

c  n = 183; no. of events = 64; cumulative days of follow-up = 179,762.

d HR is for a 1–standard deviation change in the psychosocial factor adjusted for age at assessment, race/ethnicity, study center, maternal education, body mass index percentile, breast cancer family history.

e Anxiety, depression, and somatization data from the parent-reported internalizing subscales of the Behavior Assessment System for Children-2 (percentiles). Internalizing is a composite of the other scales.

We conducted several additional analyses to explore whether maternal psychological state could explain the association between anxiety in girls and pubertal timing. There was some evidence that mothers’ self-reports of their own anxiety was associated with earlier onset of breast development in their daughters (Table 4); however, after the inclusion of the maternal report of the daughter’s anxiety and maternal self-reported anxiety in the same model, the association with maternal anxiety was weaker (HR = 1.09, 95% CI: 0.95, 1.25), whereas the association with maternal report of daughter’s anxiety symptoms remained statistically significant (HR = 1.17, 95% CI: 1.01, 1.35). There was little consistent evidence for associations between stress, anxiety, and depression in the mother, or family communication and functioning, and the development of pubertal characteristics in the daughter (Table 4, Web Tables 2 and 3). There was no statistical evidence for multiplicative interaction between anxiety in mothers and daughters in relation to the onset of breast development (P = 0.57). We assessed the association of anxiety in daughters with the timing of breast development onset separately for those with mothers who had baseline anxiety scores below the median and those with scores equal to or greater than the median. The results were virtually identical (HR = 1.18, 95% CI: 0.97, 1.44; and HR = 1.19, 95% CI: 0.99, 1.44, respectively).

Table 4.

Association of Maternal Self-Report of Internalizing Symptoms and Family Functioning With Subsequent Timing of Breast Development Onset in All Girls Recruited Before Onset, Mothers (n = 821) From the Lessons in Epidemiology and Genetics of Adult Cancer From Youth Girls Study, 2011–2016

Symptom in Mothers and Families No. Events Days of Follow-up HR a 95% CI
Stressb 323 243 207,186 1.06 0.93, 1.21 0.41
Anxietyc 324 245 207,894 1.14 1.00, 1.30 0.05
Depressionc 323 243 207,400 1.02 0.89, 1.16 0.82
Family communicationd 314 237 202,823 1.11 0.97, 1.28 0.14
Family functioningd 319 242 204,972 1.10 0.96, 1.26 0.16

Abbreviations: CI, confidence interval; HR, hazard ratio.

a HR is for a 1–standard deviation change in the psychosocial factor adjusted for daughter’s age at assessment, race/ethnicity, study center, maternal education, body mass index percentile, breast cancer family history.

b Perceived Stress Scale score.

c Hospital Anxiety and Depression Scales scores.

d General function and communication subscales of the McMaster Family Assessment Device.

When we examined internalizing symptoms in the subset of girls with clinical breast TS information, we observed similar results, albeit with less precision given the smaller subset (Web Table 4). The relationship between internalizing symptoms in girls and pubertal outcomes was generally similar in non-Hispanic White girls and in all other groups combined, although the estimates for the latter group were imprecise (Web Table 5). There was no statistical evidence for any multiplicative interactions between internalizing symptom and race/ethnicity.

DISCUSSION

Consistent with our hypothesis, we found that maternally reported anxiety symptoms in daughters before any pubertal sign and, to a lesser extent, other internalizing symptoms were associated with earlier onset of pubic hair and breast development at subsequent follow-up visits. The observed hazard ratio of 1.22 translates into breast development occurring approximately 3 months earlier, on average, in girls in the top quartile of anxiety scores (which equates approximately with 1 standard deviation above the mean) compared with girls in the lowest quartile. These associations were stronger in girls who were younger than 8 years at recruitment, a group that would be more broadly representative because it is less weighted toward girls with later pubertal onset. The associations with early breast development were not explained by maternal anxiety and were evident after accounting for other factors, including the daughter’s race/ethnicity and BMI percentile, maternal education, and the presence of a BCFH. We did not find any association of maternally reported internalizing symptoms with subsequent menarche.

The first sign of puberty in girls is the onset of breast development and/or the appearance of pubic hair (25), with menarche generally occurring a few years later. The age of pubertal onset can vary considerably between individual girls (26, 27). There is accumulating evidence that, in developed countries over recent decades, the onset of breast development is occurring earlier, whereas the age at menarche has remained stable (1, 2). Earlier pubertal signs in girls are an issue of concern because they have been associated with several adverse psychosocial and cardiometabolic health outcomes (1, 3, 4). Early breast development has been associated with an approximate 20% increased breast cancer risk, independent of age at menarche (28). However, most epidemiologic studies of pubertal timing and health outcomes have been focused on the relationship of menarche timing with health outcomes rather than pubertal onset.

Many factors contribute to the variation in pubertal timing in girls. Genetics plays a role (2) but cannot account for secular trends. Obesity contributes to earlier pubertal onset, but other factors are likely involved (1, 2, 4). Although energetic stress associated with severe malnutrition is associated with delayed puberty, environments related to psychosocial stress are associated with earlier pubertal development (1). The underlying theory for this relationship is the evolutionary benefit from earlier puberty and reproduction in girls growing up in adverse conditions, as long as there are sufficient resources for physical development and reproduction (5, 29). Consistent with this theory is that adverse socioeconomic and/or family circumstances are associated with earlier puberty in girls (1, 3). Psychosocial stress in girls may mediate the relationship between adverse environments and pubertal timing (30).

In nearly all studies to date on the relationship between stress and pubertal timing in girls, only external stressors were considered; how girls respond was not. In a small study of 28 girls aged 12–15 years at assessment, recalled anxiety or anxiety combined with depression were associated with earlier menarche, but the retrospective nature of that study is a major limitation, because recalled psychological state could be influenced by current state (7). In the prospective Millennium Cohort Study of 5,839 girls, maternally reported socioemotional difficulties at age 7 years were associated with menarche by age 11 years (6). To our knowledge, there are no studies on the relationship of anxiety and other internalizing symptoms in prepubertal girls and the timing of pubertal onset.

It is interesting that in our prospective study, prepubertal anxiety was associated with earlier puberty onset but not with menarche, despite greater statistical power for the latter outcome. This result suggests the psychosocial status of girls is primarily associated with earlier, but not later, stages of pubertal development. That association is not consistent with evolutionary theory, by which an earlier transition to full reproductive status in stressful conditions would be expected (3). However, in a study of 114 girls and boys, among children with low parental supportiveness, those exhibiting a high level of sympathetic nervous system reactivity had more rapid pubertal development, defined by TS, specifically before age 12.5 years, compared with children with low reactivity, but differences diminished with age (31). Some individuals may develop more rapidly only at early or later stages (31).

The key strength of our study is the prospective design that allowed us to examine the relationship of psychosocial factors in girls before the appearance of pubertal signs with subsequent pubertal developmental milestones. We found no evidence for differences by race/ethnicity, although we were limited by statistical power. Most mothers (78%) had a bachelor’s or graduate degree, limiting the socioeconomic diversity of our cohort. Our cohort was enriched for girls with a BCFH, which could alter the prevalence of internalizing symptoms, but we have not observed differences in the prevalence of internalizing symptoms in girls with and those without a BCFH (16) The girls had mean percentile internalizing symptom scores close to 50% and the proportion with clinically high values of anxiety symptoms, 12.5%, was within the broad range of anxiety prevalence observed in other populations (32) and consistent with the 12.6% prevalence of clinical anxiety in a recent, large, community-based sample (33).

The main limitation of the study is that mothers provided information on both the psychological and pubertal status of the daughters, albeit using different instruments and at different times, which allowed us to assess a temporal relationship. The literature is variable regarding the consistency of mother versus child reports of anxiety symptoms. In general, the agreement is low to moderate and mothers often under-report symptoms (32, 33). In the girls aged ≥10 years in the LEGACY Girls Study who reported their own anxiety and depression symptoms, the percentile scores were moderately correlated with the maternally reported scores (Spearman ρ = 0.45 and 0.41, respectively, both with P < 0.001). The psychological status of mothers can influence the agreement, but the reported direction of this influence is quite variable (32, 33). It is important to note that our finding of an association between mother-reported child anxiety symptoms and breast development onset did not differ by self-reported anxiety in the mothers. By age 10 years, many girls had started showing the first signs of puberty; thus, our outcomes relied on maternal report. With respect to the assessment of pubertal status, we have previously shown good reliability of maternal reports in our cohort within a subset of girls who also had standardized clinical assessment of breast development (14). We also observed similar findings when we used clinical breast TS as the outcome within this subset, indicating that it is unlikely that our findings are explained by biased maternal reporting. We did not perform clinical examination of pubic hair, but we note that the mother-daughter agreement for pubic hair onset in girls ≥10 years was moderate to good (κ = 0.69), and in reports of the limited studies on the topic, authors suggest self-staging may be more reliable than maternal reporting for this outcome (14). Measurement error may have attenuated the associations we observed, but research is needed using multi-informant approaches for psychosocial measures and clinical assessment of pubertal characteristics (32, 33) to confirm and expand on our findings.

We cannot exclude the possibility of reverse causality, where anxiety increased as a result of early hormonal changes before the physical signs of puberty. The temporality of events could be examined in research incorporating sequential measurements of hormone metabolites, which can be assessed in urine samples.

Our results suggest that girls who show signs of anxiety before the first signs of puberty are more likely to enter puberty at an earlier age, although more work is needed to confirm this finding. The findings are consistent with the concept that psychosocial stress is associated with earlier puberty in girls (3), but we provide an additional perspective to previous work that linked exposure to stressful environments, such as low socioeconomic status and high familial conflict, to earlier pubertal development (1, 5). Our results suggest the ability of young girls to cope with stress, manifested by the presence or absence of internalizing symptoms, may be relevant to the onset of puberty. This finding lends support to screening and treating youth for anxiety (34), which do not require the use of medications, because there are other evidence-based interventions to reduce youth anxiety (34, 35). As indicated by our results, such interventions may not only benefit stress and coping but may also have the incremental benefit of reducing the risk of earlier pubertal onset and the associated psychological and physical effects.

Supplementary Material

Web_Material_kwaa223

ACKNOWLEDGMENTS

Author affiliations: Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada (Julia A. Knight, Danielle Hanna, Gord Glendon, Irene L. Andrulis); Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada (Julia A. Knight); Mailman School of Public Health, Columbia University, New York, New York, United States (Rebecca D. Kehm, Mandy Goldberg, Lauren C. Houghton, Mary Beth Terry); Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States (Lisa Schwartz); Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States (Lisa Schwarz); College of Social Work, University of Utah, Salt Lake City, Utah, United States (Caren J. Frost); Herbert Irving Comprehensive Cancer Center, New York, New York, United States (Wendy K, Chung, Lauren C. Houghton, Mary Beth Terry); Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States (Wendy K. Chung); Huntsman Cancer Institute, Salt Lake City, Utah, United States (Sarah Colonna, Saundra S. Buys); Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California, Davis, Sacramento, California, United States (Theresa H.M. Keegan); Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States (Mary B. Daly); Department of Molecular Genetics, University of Toronto, Toronto, Canada, United States (Irene L. Andrulis); Departments of Epidemiology and Population Health and of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, United States (Esther M. John); and Departments of Medicine and Hematology/Oncology and of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States (Angela R. Bradbury).

This work was supported by the National Cancer Institute at the National Institutes of Health (grants CA138638 to E.M.J.; CA138819 to M.B.D.; CA138822 to M.B.T.; and CA138844 to I.L.A.). I.L.A. holds the Anne and Max Tanenbaum Chair in Molecular Medicine at Mount Sinai Hospital and the University of Toronto.

The authors thank their colleagues at the participating family genetics and oncology clinics.

Conflict of interest: none declared.

REFERENCES

  • 1. Walvoord  EC. The timing of puberty: is it changing? Does it matter?  J Adolesc Health. 2010;47(5):433–439. [DOI] [PubMed] [Google Scholar]
  • 2. Biro  FM, Kiess  W. Contemporary trends in onset and completion of puberty, gain in height and adiposity. Endocr Dev. 2016;29:122–133. [DOI] [PubMed] [Google Scholar]
  • 3. Ellis  BJ, Del Giudice  M. Developmental adaptation to stress: an evolutionary perspective. Annu Rev Psychol. 2019;70:111–139. [DOI] [PubMed] [Google Scholar]
  • 4. McDonald  JA, Eng  SM, Dina  OO, et al.  Infection and pubertal timing: a systematic review. J Dev Orig Health Dis. 2016;7(6):636–651. [DOI] [PubMed] [Google Scholar]
  • 5. Ellis  BJ. Timing of pubertal maturation in girls: an integrated life history approach. Psychol Bull. 2004;130(6):920–958. [DOI] [PubMed] [Google Scholar]
  • 6. Kelly  Y, Zilanawala  A, Sacker  A, et al.  Early puberty in 11-year-old girls: Millennium Cohort Study findings. Arch Dis Child. 2017;102(3):232–237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kim  K, Smith  PK. Childhood stress, behavioural symptoms and mother-daughter pubertal development. J Adolesc. 1998;21(3):231–240. [DOI] [PubMed] [Google Scholar]
  • 8. John  EM, Terry  MB, Keegan  TH, et al.  The LEGACY Girls Study; growth and development in the context of breast cancer family history. Epidemiology. 2016;27(3):438–448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Terry  MB, Keegan  THM, Houghton  LC, et al.  Pubertal development in girls by breast cancer family history: the LEGACY girls cohort. Breast Cancer Res. 2017;19(1):69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. John  EM, Hopper  JL, Beck  JC, et al.  The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004;6(4):R375–R389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Terry  MB, Phillips  KA, Daly  MB, et al.  Cohort profile: the Breast Cancer Prospective Family Study cohort (ProF-SC). Int J Epidemiol. 2016;45(3):683–692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Morris  NM, Udry  JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc. 1980;9(3):271–280. [DOI] [PubMed] [Google Scholar]
  • 13. Marshall  WA, Tanner  JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Terry  MB, Goldberg  M, Schechter  S, et al.  Comparison of clinical, maternal, and self pubertal assessments; implications for health studies. Pediatrics. 2016;138(1):e20154571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Centers for Disease Control and Prevention, National Center for Health Statistics . Individual growth charts. http://www.cdc.gov/growthcharts/charts.htm. Accessed April 14, 2016.
  • 16. Bradbury  AR, Patrick-Miller  L, Schwartz  L, et al.  Psychosocial adjustment in school-age girls with a family history of breast cancer. Pediatrics. 2015;136(5):927–937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Reynolds  CR, Kamphaus  RW. BASC-2 Behavioural Assessment for Children Manual. 2nd ed. Minneapolis, MN: Pearson; 2004. [Google Scholar]
  • 18. Zigmond  AS, Snaith  RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. [DOI] [PubMed] [Google Scholar]
  • 19. Bjelland  I, Dahl  AA, Haug  TT, et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. [DOI] [PubMed] [Google Scholar]
  • 20. Cohen  S, Kamarck  T, Mermelstein  R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–396. [PubMed] [Google Scholar]
  • 21. Byles  J, Byrne  C, Boyle  MH, et al.  Ontario Child Health Study: reliability and validity of the general functioning subscale of the McMaster Family Assessment Device. Fam Process. 1988;27(1):97–104. [DOI] [PubMed] [Google Scholar]
  • 22. Epstein  NB, Baldwin  LS, Bishop  DS. The McMaster Family Assessment Device. J Marital Fam Ther. 1983;9(2):171–180. [Google Scholar]
  • 23. Cox  DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187–220. [Google Scholar]
  • 24. Carroll  KJ. On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials. 2003;24(6):682–701. [DOI] [PubMed] [Google Scholar]
  • 25. Biro  FM, Huang  B, Daniels  SR, et al.  Pubarche as well as thelarche may be a marker for the onset of puberty. J Pediatri Adolesc Gynecol. 2008;21(6):323–328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Herman-Giddens  ME, Slora  EJ, Wasserman  RC, et al.  Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99(4):505–512. [DOI] [PubMed] [Google Scholar]
  • 27. Biro  FM, Greenspan  LC, Galvez  MP, et al.  Onset of breast development in a longitudinal cohort. Pediatrics. 2013;132(6):1019–1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Bodicoat  DH, Schoemaker  MJ, Jones  ME, et al.  Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res. 2014;16(1):R18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Belsky  J, Steinberg  L, Draper  P. Childhood experience, interpersonal development, and reproductive strategy: an evolutionary theory of socialization. Child Dev. 1991;62(4):647–670. [DOI] [PubMed] [Google Scholar]
  • 30. Hiatt  RA, Stewart  SL, Hoeft  KS, et al.  Childhood socioeconomic position and pubertal onset in a cohort of multiethnic girls: implications for breast cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1714–1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Ellis  BJ, Shirtcliff  EA, Boyce  WT, et al.  Quality of early family relationships and the timing and tempo of puberty: effects depend on biological sensitivity to context. Dev Psychopathol. 2011;23(1):85–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Affrunti  NW, Woodruff-Borden  J. The effect of maternal psychopathology on parent-child agreement of child anxiety symptoms: a hierarchical linear modeling approach. J Anxiety Disord. 2015;32:56–65. [DOI] [PubMed] [Google Scholar]
  • 33. Pereira  AI, Muris  P, Barros  L, et al.  Agreement and discrepancy between mother and child in the evaluation of children’s anxiety symptoms and anxiety life interference. Eur Child Adolesc Psychiatry. 2015;24(3):327–337. [DOI] [PubMed] [Google Scholar]
  • 34. Wissow  LS, van  Ginneken  N, Chandna  J, et al.  Integrating children’s mental health into primary care. Pediatr Clin North Am. 2016;63(1):97–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Stoll  RD, Pina  AA, Schleider  J. Brief, non-pharmacological, interventions for pediatric anxiety: meta-analysis and evidence base status. J Clin Child Adolesc Psychol. 2020;49(4):435–459. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Web_Material_kwaa223

Articles from American Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES